These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Defibrotide prevents the activation of macrovascular and microvascular endothelia caused by soluble factors released to blood by autologous hematopoietic stem cell transplantation. Palomo M, Diaz-Ricart M, Rovira M, Escolar G, Carreras E. Biol Blood Marrow Transplant; 2011 Apr; 17(4):497-506. PubMed ID: 21126597 [Abstract] [Full Text] [Related]
5. Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation. Woywodt A, Haubitz M, Buchholz S, Hertenstein B. Bone Marrow Transplant; 2004 Dec; 34(12):1015-23. PubMed ID: 15516935 [Abstract] [Full Text] [Related]
6. [Allogeneic hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis type 1: a case report]. Ou RM, Wang L, Zheng LL, Yao MD, Jiang WT, Zhou CH. Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):181-3. PubMed ID: 16787585 [Abstract] [Full Text] [Related]
7. Cytopenia and hematopoietic recovery after low intensity conditioning transplants. Kostova G, Heim D, Passweg J, Buser A, Tichelli A, Gratwohl A. Croat Med J; 2004 Aug; 45(4):445-50. PubMed ID: 15311417 [Abstract] [Full Text] [Related]
19. Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis. Wu Q, Chen H, Fang J, Xie W, Hong M, Xia L. Leuk Res; 2012 Mar; 36(3):275-80. PubMed ID: 21917312 [Abstract] [Full Text] [Related]